March 24, 2025

The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor-positive endometrial cancer.

March 25, 2025

Local 12 highlighted University of Cincinnati Cancer Center researcher Davendra Sohal and patient Ron Solomon who is enrolled in a pancreatic cancer trial targeting a genetic mutation called KRAS.

March 21, 2025

MSN highlighted research led by the University of Cincinnati's Jed Hartings detailing how automation and machine learning can aid clinicians treating patients with spreading depolarizations, sometimes referred to as “brain tsunamis.”

February 24, 2025

A new University of Cincinnati trial will compare brain accessibility of two types of omega-3 supplements in elderly adults at risk for dementia.

March 5, 2025

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy procedures.

March 4, 2025

Xuefeng Wang, an associate professor at the University of Cincinnati’s Hoxworth Blood Center, is the recipient of a grant from the National Institutes of Health, as well as corresponding author of recently published research in Nature Communications.

March 28, 2025

The Cincinnati Business Courier highlighted a $1.2 million grant received by the University of Cincinnati Cancer Center's Timothy Phoenix and colleagues at Dana-Farber Cancer Institute and the German Cancer Research Center to study pediatric low-grade gliomas.

April 4, 2025

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that an assay that includes an assessment of cancer stem cell sensitivity to chemotherapy can accurately decide more effective treatments and lead to increased outcomes for patients with platinum-resistant ovarian cancer.

April 7, 2025

MSN and MSN UK highlighted results from a new Phase 3 trial published in the journal npj Precision Oncology that found a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ovarian cancer.

April 3, 2025

Second-year medical sciences student Jay Patel is pursuing his passions at UC — conducting cancer research, exploring public policy as a Portman Fellow, and leading an international nonprofit foundation.